| Symbol | CFRXQ |
|---|---|
| Name | CONTRAFECT CORPORATION |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 10701 United States NY 28 Wells Avenue 3rd Floor |
| Telephone | (914) 207-2300 |
| Fax | — |
| — | |
| Website | https://www.contrafect.com/ |
| Incorporation | US |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001478069 |
| Description | ContraFect is a clinical-stage biotechnology company focused on discovering and developing biologic therapies for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings. Additional info from OTC: |
New Form SEC STAFF ACTION - CONTRAFECT Corp Filed: 2025-04-28 AccNo: 9999999997-25-002090 Size: 3 KB
Read moreExpert Market symbol attribute type Security_Name was changed. Previous value: -. New value: CONTRAFECT CORP.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: CONTRAFECT CORP.
Read morePink Limited symbol attribute type Security_Name was changed. Previous value: -. New value: CONTRAFECT CORP.
Read moreNew Form SC 13G/A - CONTRAFECT Corp Filed: 2024-02-14 AccNo: 0001172661-24-001220 Size: 90 KB
Read more